AT ELANA 841P Posterior Chamber Intraocular Lens for Correction of Aphakia Following Cataract Removal
NCT: NCT06264232 · COMPLETED
Brief Summary
The goal of this clinical trial is to demonstrate the safety and effectiveness of the full visual range AT ELANA 841P IOL when used to treat adult patients having cataract surgery. Subjects will be randomly selected to receive a pair of IOLs, either the AT ELANA 841P or CT LUCIA 621P lens design. All patients will undergo surgery in both eyes, and they will receive follow up care for up to 6-months. During this time, all patients will undergo thorough eye exams at every study visit and complete questionnaires about their quality of vision post-surgery.
Frequently Asked Questions
What is AT ELANA 841P Posterior Chamber Intraocular Lens for Correction of Aphakia Following Cataract Removal?
AT ELANA 841P Posterior Chamber Intraocular Lens for Correction of Aphakia Following Cataract Removal is a clinical trial registered under NCT06264232. Current status: COMPLETED.
What is the status of NCT06264232?
The current status of NCT06264232 (AT ELANA 841P Posterior Chamber Intraocular Lens for Correction of Aphakia Following Cataract Removal) is: COMPLETED.
When did AT ELANA 841P Posterior Chamber Intraocular Lens for Correction of Aphakia Following Cataract Removal start?
AT ELANA 841P Posterior Chamber Intraocular Lens for Correction of Aphakia Following Cataract Removal started on 2024-07-12.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.